Cargando…

Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma

PURPOSE: Surgical margin status is a surrogate marker for residual tumors after breast-conserving surgery (BCS). A comparison of ipsilateral breast tumor recurrence (IBTR) rates between re-excision combined with radiotherapy (excision with RTx) and RTx alone, following the confirmation of ductal car...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jun-Hee, Lee, Hyunjun, Bang, Yoon Ju, Ryu, Jai Min, Lee, Se Kyung, Yu, Jonghan, Lee, Jeong Eon, Kim, Seok Won, Nam, Seok Jin, Chae, Byung Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411028/
https://www.ncbi.nlm.nih.gov/pubmed/36031753
http://dx.doi.org/10.4048/jbc.2022.25.e36
_version_ 1784775228931440640
author Lee, Jun-Hee
Lee, Hyunjun
Bang, Yoon Ju
Ryu, Jai Min
Lee, Se Kyung
Yu, Jonghan
Lee, Jeong Eon
Kim, Seok Won
Nam, Seok Jin
Chae, Byung Joo
author_facet Lee, Jun-Hee
Lee, Hyunjun
Bang, Yoon Ju
Ryu, Jai Min
Lee, Se Kyung
Yu, Jonghan
Lee, Jeong Eon
Kim, Seok Won
Nam, Seok Jin
Chae, Byung Joo
author_sort Lee, Jun-Hee
collection PubMed
description PURPOSE: Surgical margin status is a surrogate marker for residual tumors after breast-conserving surgery (BCS). A comparison of ipsilateral breast tumor recurrence (IBTR) rates between re-excision combined with radiotherapy (excision with RTx) and RTx alone, following the confirmation of ductal carcinoma in situ (DCIS) in the resection margin after BCS, has not been reported previously. Therefore, in the present study, the clinical characteristics of DCIS involvement in the surgical resection margin between excision with RTx and RTx alone were investigated, and the IBTR rate was compared. METHODS: We analyzed 8,473 patients treated with BCS followed by RTx between January 2013 and December 2019. Patients were divided into 2 groups based on surgical resection margin status in permanent pathology, and superficial and deep margins were excluded. Patients who underwent re-excision with DCIS confirmed in the resection margin were identified and the IBTR rate was examined. RESULTS: Among 8,473 patients treated with BCS, 494 (5.8%) had positive surgical resection margins. The median follow-up period was 47 months. Among the 494 patients with a positive resection margin, 368 (74.5%) had residual DCIS at the surgical resection margin in the final pathology. Among those with confirmed DCIS at the resection margin, 24 patients (6.5%) were re-excised, and 344 patients (93.5%) underwent RTx after observation. The IBTR rates were 4.2% and 1.2% in the re-excision and observation groups, respectively. IBTR-free survival analysis revealed no significant difference between the excision with RTx and RTx-only groups (p = 0.262). CONCLUSION: The IBTR rate did not differ between the excision with RTx and RTx-only groups when DCIS was confirmed at the resection margins. This suggests that RTx and close observation without re-excision could be an option, even in cases where minimal involvement of DCIS is confirmed on surgical resection.
format Online
Article
Text
id pubmed-9411028
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Breast Cancer Society
record_format MEDLINE/PubMed
spelling pubmed-94110282022-09-06 Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma Lee, Jun-Hee Lee, Hyunjun Bang, Yoon Ju Ryu, Jai Min Lee, Se Kyung Yu, Jonghan Lee, Jeong Eon Kim, Seok Won Nam, Seok Jin Chae, Byung Joo J Breast Cancer Original Article PURPOSE: Surgical margin status is a surrogate marker for residual tumors after breast-conserving surgery (BCS). A comparison of ipsilateral breast tumor recurrence (IBTR) rates between re-excision combined with radiotherapy (excision with RTx) and RTx alone, following the confirmation of ductal carcinoma in situ (DCIS) in the resection margin after BCS, has not been reported previously. Therefore, in the present study, the clinical characteristics of DCIS involvement in the surgical resection margin between excision with RTx and RTx alone were investigated, and the IBTR rate was compared. METHODS: We analyzed 8,473 patients treated with BCS followed by RTx between January 2013 and December 2019. Patients were divided into 2 groups based on surgical resection margin status in permanent pathology, and superficial and deep margins were excluded. Patients who underwent re-excision with DCIS confirmed in the resection margin were identified and the IBTR rate was examined. RESULTS: Among 8,473 patients treated with BCS, 494 (5.8%) had positive surgical resection margins. The median follow-up period was 47 months. Among the 494 patients with a positive resection margin, 368 (74.5%) had residual DCIS at the surgical resection margin in the final pathology. Among those with confirmed DCIS at the resection margin, 24 patients (6.5%) were re-excised, and 344 patients (93.5%) underwent RTx after observation. The IBTR rates were 4.2% and 1.2% in the re-excision and observation groups, respectively. IBTR-free survival analysis revealed no significant difference between the excision with RTx and RTx-only groups (p = 0.262). CONCLUSION: The IBTR rate did not differ between the excision with RTx and RTx-only groups when DCIS was confirmed at the resection margins. This suggests that RTx and close observation without re-excision could be an option, even in cases where minimal involvement of DCIS is confirmed on surgical resection. Korean Breast Cancer Society 2022-08-16 /pmc/articles/PMC9411028/ /pubmed/36031753 http://dx.doi.org/10.4048/jbc.2022.25.e36 Text en © 2022 Korean Breast Cancer Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Jun-Hee
Lee, Hyunjun
Bang, Yoon Ju
Ryu, Jai Min
Lee, Se Kyung
Yu, Jonghan
Lee, Jeong Eon
Kim, Seok Won
Nam, Seok Jin
Chae, Byung Joo
Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
title Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
title_full Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
title_fullStr Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
title_full_unstemmed Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
title_short Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
title_sort comparison of recurrence rate between re-excision with radiotherapy and radiotherapy-only groups in surgical margin involvement of in situ carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411028/
https://www.ncbi.nlm.nih.gov/pubmed/36031753
http://dx.doi.org/10.4048/jbc.2022.25.e36
work_keys_str_mv AT leejunhee comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT leehyunjun comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT bangyoonju comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT ryujaimin comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT leesekyung comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT yujonghan comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT leejeongeon comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT kimseokwon comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT namseokjin comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma
AT chaebyungjoo comparisonofrecurrenceratebetweenreexcisionwithradiotherapyandradiotherapyonlygroupsinsurgicalmargininvolvementofinsitucarcinoma